{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T07:27:42Z","timestamp":1771572462997,"version":"3.50.1"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s00284-025-04349-0","type":"journal-article","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T07:09:08Z","timestamp":1752476948000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Innovative Non-antibiotic Strategies for Combating Methicillin-Resistant Staphylococcus aureus in Diabetic Foot Infections"],"prefix":"10.1007","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8990-7036","authenticated-orcid":false,"given":"Mohsen","family":"Nazari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Bahrami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faezeh","family":"Jahanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,14]]},"reference":[{"key":"4349_CR1","doi-asserted-by":"crossref","unstructured":"Boulton AJ, Armstrong DG, Hardman MJ, Malone M, Embil JM, Attinger CE et al (2020) Diagnosis and management of diabetic foot infections","DOI":"10.2337\/db2020-01"},{"key":"4349_CR2","doi-asserted-by":"crossref","unstructured":"Nazari M, Taheri M, Nouri F, Bahmanzadeh M, Alikhani MY (2024) Time-kill curve analysis of fucoidan combination with conventional antibiotics against biofilms formation of methicillin-resistant Staphylococcus aureus and Acinetobacter baumannii clinical isolates. Chemotherapy: 1\u201318","DOI":"10.1159\/000542826"},{"issue":"3","key":"4349_CR3","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1177\/1534734619853668","volume":"18","author":"V Viswanathan","year":"2019","unstructured":"Viswanathan V, Pendsey S, Radhakrishnan C, Rege TD, Ahdal J, Jain R (2019) Methicillin-resistant Staphylococcus aureus in diabetic foot infection in India: a growing menace. Int J Low Extrem Wounds 18(3):236\u2013246","journal-title":"Int J Low Extrem Wounds"},{"issue":"1","key":"4349_CR4","doi-asserted-by":"publisher","first-page":"286","DOI":"10.4314\/ahs.v21i1.37","volume":"21","author":"L Thimmappa","year":"2021","unstructured":"Thimmappa L, Bhat A, Hande M, Mukhopadhyay C, Devi E, Nayak B et al (2021) Risk factors for wound infection caused by methicillin resistant Staphylococcus aureus among hospitalized patients: a case control study from a tertiary care hospital in India. Afr Health Sci 21(1):286\u2013294","journal-title":"Afr Health Sci"},{"issue":"8","key":"4349_CR5","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.12998\/wjcc.v11.i8.1669","volume":"11","author":"T Matijevi\u0107","year":"2023","unstructured":"Matijevi\u0107 T, Talapko J, Me\u0161trovi\u0107 T, Matijevi\u0107 M, Eri\u0107 S, Eri\u0107 I et al (2023) Understanding the multifaceted etiopathogenesis of foot complications in individuals with diabetes. World J Clin Cases 11(8):1669","journal-title":"World J Clin Cases"},{"issue":"6","key":"4349_CR6","doi-asserted-by":"publisher","first-page":"680","DOI":"10.4239\/wjd.v14.i6.680","volume":"14","author":"AA Rajab","year":"2023","unstructured":"Rajab AA, Hegazy WA (2023) What\u2019s old is new again: insights into diabetic foot microbiome. World J Diabetes 14(6):680","journal-title":"World J Diabetes"},{"key":"4349_CR7","doi-asserted-by":"publisher","first-page":"5419","DOI":"10.1111\/1475-6773.13063","volume":"53","author":"RE Nelson","year":"2018","unstructured":"Nelson RE, Jones M, Liu CF, Samore MH, Evans ME, Stevens VW et al (2018) The impact of healthcare-associated methicillin-resistant Staphylococcus aureus infections on postdischarge health care costs and utilization across multiple health care systems. Health Serv Res 53:5419\u20135437","journal-title":"Health Serv Res"},{"issue":"3","key":"4349_CR8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1080\/14728214.2019.1677607","volume":"24","author":"M Bassetti","year":"2019","unstructured":"Bassetti M, Russo A, Carnelutti A, Wilcox M (2019) Emerging drugs for treating methicillin-resistant Staphylococcus aureus. Expert Opin Emerg Drugs 24(3):191\u2013204","journal-title":"Expert Opin Emerg Drugs"},{"issue":"1","key":"4349_CR9","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12941-024-00760-w","volume":"23","author":"M Nazari","year":"2024","unstructured":"Nazari M, Taheri M, Nouri F, Bahmanzadeh M, Alikhani MY (2024) The antimicrobial and antibiofilm effects of gentamicin, imipenem, and fucoidan combinations against dual-species biofilms of Staphylococcus aureus and Acinetobacter baumannii isolated from diabetic foot ulcers. Ann Clin Microbiol Antimicrob 23(1):101","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"1","key":"4349_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40001-024-02255-y","volume":"30","author":"M Nazari","year":"2025","unstructured":"Nazari M, Shokoohizadeh L, Taheri M (2025) Natural products in the treatment of diabetic foot infection. Eur J Med Res 30(1):1\u201317","journal-title":"Eur J Med Res"},{"issue":"2","key":"4349_CR11","doi-asserted-by":"publisher","first-page":"74","DOI":"10.52547\/vacres.7.2.74","volume":"7","author":"M Nazari","year":"2020","unstructured":"Nazari M, Badmasti F (2020) In silico evaluation of a mutant toxic shock syndrome toxin-1 (TSST-1) of Staphylococcus aureus as a putative vaccine candidate. Vaccine Res 7(2):74\u201379","journal-title":"Vaccine Res"},{"key":"4349_CR12","doi-asserted-by":"publisher","unstructured":"Vestergaard M, Frees D, Ingmer H (2019) Antibiotic resistance and the MRSA problem. Microbiol Spectrum 7(2). https:\/\/doi.org\/10.1128\/microbiolspec.gpp3-0057-2018","DOI":"10.1128\/microbiolspec.gpp3-0057-2018"},{"issue":"1","key":"4349_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12866-023-03142-y","volume":"24","author":"S Shahrokh","year":"2024","unstructured":"Shahrokh S, Tabatabaee A, Yazdi M, Siavash M (2024) Proportion of toxin and non-toxin virulence factors of Staphylococcus aureus isolates from diabetic foot infection: a systematic review and meta-analysis. BMC Microbiol 24(1):1","journal-title":"BMC Microbiol"},{"key":"4349_CR14","doi-asserted-by":"crossref","unstructured":"Bhattacharya M, Horswill AR (2024) The role of human extracellular matrix proteins in defining Staphylococcus aureus biofilm infections. FEMS Microbiol Rev 48(1):fuae002","DOI":"10.1093\/femsre\/fuae002"},{"issue":"7","key":"4349_CR15","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3390\/toxins8070209","volume":"8","author":"C Dunyach-Remy","year":"2016","unstructured":"Dunyach-Remy C, Ngba Essebe C, Sotto A, Lavigne J-P (2016) Staphylococcus aureus toxins and diabetic foot ulcers: role in pathogenesis and interest in diagnosis. Toxins 8(7):209","journal-title":"Toxins"},{"issue":"12","key":"4349_CR16","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1007\/s10096-020-03984-8","volume":"39","author":"K Shettigar","year":"2020","unstructured":"Shettigar K, Murali TS (2020) Virulence factors and clonal diversity of Staphylococcus aureus in colonization and wound infection with emphasis on diabetic foot infection. Eur J Clin Microbiol Infect Dis 39(12):2235\u20132246","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"4349_CR17","doi-asserted-by":"publisher","first-page":"1204428","DOI":"10.3389\/fmicb.2023.1204428","volume":"14","author":"H Patel","year":"2023","unstructured":"Patel H, Rawat S (2023) A genetic regulatory see-saw of biofilm and virulence in MRSA pathogenesis. Front Microbiol 14:1204428","journal-title":"Front Microbiol"},{"key":"4349_CR18","volume-title":"Identification of staphylococcal genes involved in resistance to the human antimicrobial peptide LL-37","author":"P Zhang","year":"2012","unstructured":"Zhang P (2012) Identification of staphylococcal genes involved in resistance to the human antimicrobial peptide LL-37. UCL (University College London)"},{"key":"4349_CR19","unstructured":"Pitocco D, Spanu T, Di Leo M, Vitiello R, Rizzi A, Tartaglione L et al (2019) Diabetic foot infections: a comprehensive overview. Euro Rev Med Pharmacol Sci 23"},{"key":"4349_CR20","unstructured":"Marron CD (2010) 20 superficial sepsis, cutaneous abscess and necrotising fasciitis. BLBK236-FM BLBK236-Brooks Trim: 219 mm\u00d7 276 mm February 8, 2010 21: 30 Char Count=. 2010"},{"issue":"4","key":"4349_CR21","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.emc.2018.06.005","volume":"36","author":"A Breyre","year":"2018","unstructured":"Breyre A, Frazee BW (2018) Skin and soft tissue infections in the emergency department. Emergency Med Clin 36(4):723\u2013750","journal-title":"Emergency Med Clin"},{"issue":"4","key":"4349_CR22","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1089\/sur.2020.436","volume":"22","author":"TM Duane","year":"2021","unstructured":"Duane TM, Huston JM, Collom M, Beyer A, Parli S, Buckman S et al (2021) Surgical infection society 2020 updated guidelines on the management of complicated skin and soft tissue infections. Surg Infect 22(4):383\u2013399","journal-title":"Surg Infect"},{"issue":"16","key":"4349_CR23","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.3390\/molecules25163601","volume":"25","author":"V Silva","year":"2020","unstructured":"Silva V, Peirone C, Amaral JS, Capita R, Alonso-Calleja C, Marques-Magallanes JA et al (2020) High efficacy of ozonated oils on the removal of biofilms produced by methicillin-resistant Staphylococcus aureus (MRSA) from infected diabetic foot ulcers. Molecules 25(16):3601","journal-title":"Molecules"},{"issue":"1","key":"4349_CR24","doi-asserted-by":"publisher","first-page":"1403019","DOI":"10.1155\/cjid\/1403019","volume":"2024","author":"M Nazari","year":"2024","unstructured":"Nazari M, Hemmati J, Asghari B (2024) Comprehensive analysis of virulence genes, antibiotic resistance, biofilm formation, and sequence types in clinical isolates of klebsiella pneumoniae. Can J Infect Dis Med Microbiol 2024(1):1403019","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"1","key":"4349_CR25","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12866-024-03249-w","volume":"24","author":"J Hemmati","year":"2024","unstructured":"Hemmati J, Nazari M, Abolhasani FS, Ahmadi A, Asghari B (2024) In vitro investigation of relationship between quorum-sensing system genes, biofilm forming ability, and drug resistance in clinical isolates of Pseudomonas aeruginosa. BMC Microbiol 24(1):99","journal-title":"BMC Microbiol"},{"issue":"7","key":"4349_CR26","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.3390\/antibiotics12071164","volume":"12","author":"F Mariani","year":"2023","unstructured":"Mariani F, Galvan EM (2023) Staphylococcus aureus in polymicrobial skinand soft tissue infections: impact of inter-species interactionsin disease outcome. Antibiotics 12(7):1164","journal-title":"Antibiotics"},{"issue":"10","key":"4349_CR27","doi-asserted-by":"publisher","first-page":"24656","DOI":"10.3390\/ijms161024656","volume":"16","author":"K Cihalova","year":"2015","unstructured":"Cihalova K, Chudobova D, Michalek P, Moulick A, Guran R, Kopel P et al (2015) Staphylococcus aureus and MRSA growth and biofilm formation after treatment with antibiotics and SeNPs. Int J Mol Sci 16(10):24656\u201324672","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4349_CR28","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1159\/000530385","volume":"15","author":"M Li","year":"2023","unstructured":"Li M, Yu J, Guo G, Shen H (2023) Interactions between macrophages and biofilm during Staphylococcus aureus-associated implant infection: difficulties and solutions. J Innate Immun 15(1):499\u2013515","journal-title":"J Innate Immun"},{"key":"4349_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.648554","volume":"12","author":"Z Versey","year":"2021","unstructured":"Versey Z, da Cruz Nizer WS, Russell E, Zigic S, DeZeeuw KG, Marek JE et al (2021) Biofilm-innate immune interface: contribution to chronic wound formation. Front Immunol 12:648554","journal-title":"Front Immunol"},{"issue":"1","key":"4349_CR30","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1080\/21505594.2017.1313372","volume":"9","author":"R Roy","year":"2018","unstructured":"Roy R, Tiwari M, Donelli G, Tiwari V (2018) Strategies for combating bacterial biofilms: a focus on anti-biofilm agents and their mechanisms of action. Virulence. 9(1):522\u2013554","journal-title":"Virulence."},{"issue":"2","key":"4349_CR31","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3390\/antibiotics12020328","volume":"12","author":"C Michaelis","year":"2023","unstructured":"Michaelis C, Grohmann E (2023) Horizontal gene transfer of antibiotic resistance genes in biofilms. Antibiotics 12(2):328","journal-title":"Antibiotics"},{"key":"4349_CR32","doi-asserted-by":"crossref","unstructured":"Ferhaoui N, Tanaka R, Sekizuka T, Kuroda M, Sebaihia M (2023) Whole genome sequencing and pan-genome analysis of Staphylococcus\/Mammaliicoccus spp. isolated from diabetic foot ulcers and contralateral healthy skin of Algerian patients. BMC Microbiol 23(1):342","DOI":"10.1186\/s12866-023-03087-2"},{"key":"4349_CR33","doi-asserted-by":"publisher","unstructured":"Di Domenico EG, Farulla I, Prignano G, Gallo MT, Vespaziani M, Cavallo I et al (2017) Biofilm is a major virulence determinant in bacterial colonization of chronic skin ulcers independently from the multidrug resistant phenotype. Int J Mol Sci 18(5). https:\/\/doi.org\/10.3390\/ijms18051077","DOI":"10.3390\/ijms18051077"},{"key":"4349_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.678771","volume":"12","author":"R Dowey","year":"2021","unstructured":"Dowey R, Iqbal A, Heller SR, Sabroe I, Prince LR (2021) A bittersweet response to infection in diabetes; targeting neutrophils to modify inflammation and improve host immunity. Front Immunol 12:678771. https:\/\/doi.org\/10.3389\/fimmu.2021.678771","journal-title":"Front Immunol"},{"key":"4349_CR35","doi-asserted-by":"publisher","unstructured":"Wang A, Lv G, Cheng X, Ma X, Wang W, Gui J et al (2020) Guidelines on multidisciplinary approaches for the prevention and management of diabetic foot disease (2020 edition). Burns Trauma 8:tkaa017. https:\/\/doi.org\/10.1093\/burnst\/tkaa017","DOI":"10.1093\/burnst\/tkaa017"},{"key":"4349_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-024-02438-3","author":"F Alenazi","year":"2025","unstructured":"Alenazi F, Khan MS (2025) Novel antimicrobial strategies for diabetic foot infections: addressing challenges and resistance. Acta Diabetol. https:\/\/doi.org\/10.1007\/s00592-024-02438-3","journal-title":"Acta Diabetol"},{"issue":"4","key":"4349_CR37","first-page":"386","volume":"104","author":"EM Matheson","year":"2021","unstructured":"Matheson EM, Bragg SW, Blackwelder RS (2021) Diabetes-related foot infections: diagnosis and treatment. Am Fam Physician 104(4):386\u2013394","journal-title":"Am Fam Physician"},{"issue":"1","key":"4349_CR38","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00441-008-0685-6","volume":"335","author":"W Bakker","year":"2009","unstructured":"Bakker W, Eringa EC, Sipkema P, van Hinsbergh VW (2009) Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity. Cell Tissue Res 335(1):165\u2013189. https:\/\/doi.org\/10.1007\/s00441-008-0685-6","journal-title":"Cell Tissue Res"},{"key":"4349_CR39","doi-asserted-by":"publisher","unstructured":"Meza CA, La Favor JD, Kim DH, Hickner RC (2019) Endothelial dysfunction: is there a hyperglycemia-induced imbalance of NOX and NOS? Int J Mol Sci 20(15). https:\/\/doi.org\/10.3390\/ijms20153775","DOI":"10.3390\/ijms20153775"},{"issue":"1","key":"4349_CR40","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41429-019-0240-6","volume":"73","author":"A Wr\u00f3bel","year":"2020","unstructured":"Wr\u00f3bel A, Arciszewska K, Maliszewski D, Drozdowska D (2020) Trimethoprim and other nonclassical antifolates an excellent template for searching modifications of dihydrofolate reductase enzyme inhibitors. J Antibiot (Tokyo) 73(1):5\u201327. https:\/\/doi.org\/10.1038\/s41429-019-0240-6","journal-title":"J Antibiot (Tokyo)"},{"key":"4349_CR41","doi-asserted-by":"publisher","unstructured":"Lade H, Kim JS (2021) Bacterial targets of antibiotics in methicillin-resistant Staphylococcus aureus. Antibiotics 10(4). https:\/\/doi.org\/10.3390\/antibiotics10040398","DOI":"10.3390\/antibiotics10040398"},{"key":"4349_CR42","doi-asserted-by":"publisher","unstructured":"Armillei MK, Lomakin IB, Del Rosso JQ, Grada A, Bunick CG (2024) Scientific rationale and clinical basis for clindamycin use in the treatment of dermatologic disease. Antibiotics 13(3). https:\/\/doi.org\/10.3390\/antibiotics13030270","DOI":"10.3390\/antibiotics13030270"},{"issue":"14","key":"4349_CR43","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.2165\/11538070-000000000-00000","volume":"70","author":"I Eleftheriadou","year":"2010","unstructured":"Eleftheriadou I, Tentolouris N, Argiana V, Jude E, Boulton AJ (2010) Methicillin-resistant Staphylococcus aureus in diabetic foot infections. Drugs 70(14):1785\u20131797. https:\/\/doi.org\/10.2165\/11538070-000000000-00000","journal-title":"Drugs"},{"issue":"3","key":"4349_CR44","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s40121-015-0077-7","volume":"4","author":"JR Smith","year":"2015","unstructured":"Smith JR, Roberts KD, Rybak MJ (2015) Dalbavancin: a novel lipoglycopeptide antibiotic with extended activity against gram-positive infections. Infect Dis Ther 4(3):245\u2013258. https:\/\/doi.org\/10.1007\/s40121-015-0077-7","journal-title":"Infect Dis Ther"},{"key":"4349_CR45","doi-asserted-by":"publisher","unstructured":"Wilkins CA, Hamman H, Hamman JH, Steenekamp JH (2024) Fixed-dose combination formulations in solid oral drug therapy: advantages, limitations, and design features. Pharmaceutics 16(2). https:\/\/doi.org\/10.3390\/pharmaceutics16020178","DOI":"10.3390\/pharmaceutics16020178"},{"issue":"7","key":"4349_CR46","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s10096-020-04121-1","volume":"41","author":"S Yaghoubi","year":"2022","unstructured":"Yaghoubi S, Zekiy AO, Krutova M, Gholami M, Kouhsari E, Sholeh M et al (2022) Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: narrative review. Eur J Clin Microbiol Infect Dis 41(7):1003\u20131022. https:\/\/doi.org\/10.1007\/s10096-020-04121-1","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"4349_CR47","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13756-018-0360-y","volume":"7","author":"JW Decousser","year":"2018","unstructured":"Decousser JW, Woerther PL, Soussy CJ, Fines-Guyon M, Dowzicky MJ (2018) The tigecycline evaluation and surveillance trial; assessment of the activity of tigecycline and other selected antibiotics against gram-positive and gram-negative pathogens from France collected between 2004 and 2016. Antimicrob Resist Infect Control 7:68. https:\/\/doi.org\/10.1186\/s13756-018-0360-y","journal-title":"Antimicrob Resist Infect Control"},{"issue":"5","key":"4349_CR48","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1592\/phco.29.5.511","volume":"29","author":"C Vidaillac","year":"2009","unstructured":"Vidaillac C, Rybak MJ (2009) Ceftobiprole: first cephalosporin with activity against methicillin-resistant Staphylococcus aureus. Pharmacotherapy 29(5):511\u2013525. https:\/\/doi.org\/10.1592\/phco.29.5.511","journal-title":"Pharmacotherapy"},{"issue":"9","key":"4349_CR49","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.3390\/antibiotics12091362","volume":"12","author":"H Lade","year":"2023","unstructured":"Lade H, Kim J-S (2023) Molecular determinants of \u03b2-lactam resistance in methicillin-resistant Staphylococcus aureus (MRSA): an updated review. Antibiotics 12(9):1362","journal-title":"Antibiotics"},{"issue":"20","key":"4349_CR50","doi-asserted-by":"publisher","first-page":"7008","DOI":"10.3390\/molecules28207008","volume":"28","author":"SS Ambade","year":"2023","unstructured":"Ambade SS, Gupta VK, Bhole RP, Khedekar PB, Chikhale RV (2023) A review on five and six-membered heterocyclic compounds targeting the penicillin-binding protein 2 (PBP2A) of methicillin-resistant Staphylococcus aureus (MRSA). Molecules 28(20):7008","journal-title":"Molecules"},{"issue":"1","key":"4349_CR51","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41413-022-00227-8","volume":"10","author":"AR Zelmer","year":"2022","unstructured":"Zelmer AR, Nelson R, Richter K, Atkins GJ (2022) Can intracellular Staphylococcus aureus in osteomyelitis be treated using current antibiotics? A systematic review and narrative synthesis. Bone Res 10(1):53","journal-title":"Bone Res"},{"issue":"3","key":"4349_CR52","doi-asserted-by":"publisher","first-page":"89","DOI":"10.17479\/jacs.2021.11.3.89","volume":"11","author":"W Alfouzan","year":"2021","unstructured":"Alfouzan W, Al-Balushi Z, Al-Maslamani M, Al-Rashed A, Al-Sabah S, Al-Salman J et al (2021) Antimicrobial management of complicated skin and soft tissue infections in an era of emerging multi-drug resistance: perspectives from 5 gulf countries. J Acute Care Surgery 11(3):89\u2013101","journal-title":"J Acute Care Surgery"},{"issue":"6","key":"4349_CR53","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1007\/s00284-021-02442-8","volume":"78","author":"BH Nataraj","year":"2021","unstructured":"Nataraj BH, Mallappa RH (2021) Antibiotic resistance crisis: an update on antagonistic interactions between probiotics and methicillin-resistant Staphylococcus aureus (MRSA). Curr Microbiol 78(6):2194\u20132211","journal-title":"Curr Microbiol"},{"key":"4349_CR54","doi-asserted-by":"crossref","unstructured":"Ryu S, Song PI, Seo CH, Cheong H, Park Y (2014) Colonization and infection of the skin by S. aureus: immune system evasion and the response to cationic antimicrobial peptides. Int J Mole Sci 15(5):8753\u20138772","DOI":"10.3390\/ijms15058753"},{"key":"4349_CR55","doi-asserted-by":"crossref","unstructured":"Sato H, Feix JB (2006) Peptide\u2013membrane interactions and mechanisms of membrane destruction by amphipathic \u03b1-helical antimicrobial peptides. Biochimica et Biophysica Acta (BBA)-Biomembranes 1758(9):1245\u20131256","DOI":"10.1016\/j.bbamem.2006.02.021"},{"key":"4349_CR56","doi-asserted-by":"crossref","unstructured":"Lee T-H, N Hall K, Aguilar M-I (2016) Antimicrobial peptide structure and mechanism of action: a focus on the role of membrane structure. Curr Top Med Chem 16(1):25\u201339","DOI":"10.2174\/1568026615666150703121700"},{"key":"4349_CR57","doi-asserted-by":"crossref","unstructured":"Graf M, Wilson DN (2019) Intracellular antimicrobial peptides targeting the protein synthesis machinery. Antimicrobial peptides: basics for clinical application: 73\u201389","DOI":"10.1007\/978-981-13-3588-4_6"},{"key":"4349_CR58","doi-asserted-by":"publisher","first-page":"3727","DOI":"10.2147\/dmso.S435062","volume":"16","author":"Z Li","year":"2023","unstructured":"Li Z, Li T, Tang J, Huang L, Ding Y, Zeng Z et al (2023) Antibacterial activity of surfactin and synergistic effect with conventional antibiotics against methicillin-resistant staphylococcus aureus isolated from patients with diabetic foot ulcers. Diabetes Metab Syndr Obes 16:3727\u20133737. https:\/\/doi.org\/10.2147\/dmso.S435062","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"5","key":"4349_CR59","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.3390\/ijms23052499","volume":"23","author":"SV Guryanova","year":"2022","unstructured":"Guryanova SV, Ovchinnikova TV (2022) Immunomodulatory and allergenic properties of antimicrobial peptides. Int J Mol Sci 23(5):2499","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4349_CR60","first-page":"220","volume":"11","author":"T Hirsch","year":"2009","unstructured":"Hirsch T, Spielmann M, Zuhaili B, Fossum M, Metzig M, Koehler T et al (2009) Human beta-defensin-3 promotes wound healing in infected diabetic wounds. J Gene Med Cross-Discipl J Res Sci Gene Transf Clin Appl 11(3):220\u2013228","journal-title":"J Gene Med Cross-Discipl J Res Sci Gene Transf Clin Appl"},{"key":"4349_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102781","volume":"64","author":"D Wang","year":"2023","unstructured":"Wang D, Li J, Luo G, Zhou J, Wang N, Wang S et al (2023) Nox4 as a novel therapeutic target for diabetic vascular complications. Redox Biol 64:102781","journal-title":"Redox Biol"},{"issue":"9","key":"4349_CR62","doi-asserted-by":"publisher","first-page":"840","DOI":"10.3390\/pharmaceutics12090840","volume":"12","author":"V Patrulea","year":"2020","unstructured":"Patrulea V, Borchard G, Jordan O (2020) An update on antimicrobial peptides (AMPs) and their delivery strategies for wound infections. Pharmaceutics 12(9):840","journal-title":"Pharmaceutics"},{"issue":"1","key":"4349_CR63","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/fcp.12499","volume":"34","author":"A Bolatchiev","year":"2020","unstructured":"Bolatchiev A, Baturin V, Bazikov I, Maltsev A, Kunitsina E (2020) Effect of antimicrobial peptides HNP-1 and hBD-1 on Staphylococcus aureus strains in vitro and in vivo. Fundam Clin Pharmacol 34(1):102\u2013108. https:\/\/doi.org\/10.1111\/fcp.12499","journal-title":"Fundam Clin Pharmacol"},{"issue":"1","key":"4349_CR64","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s12967-025-06321-9","volume":"23","author":"S Zheng","year":"2025","unstructured":"Zheng S, Tu Y, Li B, Qu G, Li A, Peng X et al (2025) Antimicrobial peptide biological activity, delivery systems and clinical translation status and challenges. J Transl Med 23(1):292","journal-title":"J Transl Med"},{"issue":"1","key":"4349_CR65","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/med.21435","volume":"38","author":"P Bastos","year":"2018","unstructured":"Bastos P, Trindade F, da Costa J, Ferreira R, Vitorino R (2018) Human antimicrobial peptides in bodily fluids: current knowledge and therapeutic perspectives in the postantibiotic era. Med Res Rev 38(1):101\u2013146","journal-title":"Med Res Rev"},{"issue":"2","key":"4349_CR66","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nmat5053","volume":"17","author":"V Cagno","year":"2018","unstructured":"Cagno V, Andreozzi P, D\u2019Alicarnasso M, Jacob Silva P, Mueller M, Galloux M et al (2018) Broad-spectrum non-toxic antiviral nanoparticles with a virucidal inhibition mechanism. Nat Mater 17(2):195\u2013203","journal-title":"Nat Mater"},{"issue":"10","key":"4349_CR67","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1099\/jmm.0.000329","volume":"65","author":"R Santos","year":"2016","unstructured":"Santos R, Gomes D, Macedo H, Barros D, Tib\u00e9rio C, Veiga AS et al (2016) Guar gum as a new antimicrobial peptide delivery system against diabetic foot ulcers Staphylococcus aureus isolates. J Med Microbiol 65(10):1092\u20131099","journal-title":"J Med Microbiol"},{"issue":"30","key":"4349_CR68","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202401793","volume":"11","author":"XY Luo","year":"2024","unstructured":"Luo XY, Hu CM, Yin Q, Zhang XM, Liu ZZ, Zhou CK et al (2024) Dual-mechanism peptide SR25 has broad antimicrobial activity and potential application for healing bacteria-infected diabetic wounds. Adv Sci (Weinh). 11(30):e2401793. https:\/\/doi.org\/10.1002\/advs.202401793","journal-title":"Adv Sci (Weinh)."},{"key":"4349_CR69","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3389\/fimmu.2013.00143","volume":"4","author":"AJ Duplantier","year":"2013","unstructured":"Duplantier AJ, van Hoek ML (2013) The human cathelicidin antimicrobial peptide LL-37 as a potential treatment for polymicrobial infected wounds. Front Immunol 4:143","journal-title":"Front Immunol"},{"issue":"1","key":"4349_CR70","doi-asserted-by":"publisher","first-page":"9984540","DOI":"10.1155\/2021\/9984540","volume":"2021","author":"R Ali","year":"2021","unstructured":"Ali R, Alireza N, Reza FM, Rahim M (2021) Accelerative effect of cinnamon nanoparticles as well as HAMLET on healing of wounds infected with MRSA in diabetic rats. Biomed Res Int 2021(1):9984540","journal-title":"Biomed Res Int"},{"issue":"1","key":"4349_CR71","doi-asserted-by":"publisher","first-page":"29707","DOI":"10.1038\/srep29707","volume":"6","author":"MF Mohamed","year":"2016","unstructured":"Mohamed MF, Abdelkhalek A, Seleem MN (2016) Evaluation of short synthetic antimicrobial peptides for treatment of drug-resistant and intracellular Staphylococcus aureus. Sci Rep 6(1):29707","journal-title":"Sci Rep"},{"issue":"2","key":"4349_CR72","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/jobm.201800412","volume":"59","author":"M Jamal","year":"2019","unstructured":"Jamal M, Bukhari SM, Andleeb S, Ali M, Raza S, Nawaz MA et al (2019) Bacteriophages: an overview of the control strategies against multiple bacterial infections in different fields. J Basic Microbiol 59(2):123\u2013133","journal-title":"J Basic Microbiol"},{"issue":"2","key":"4349_CR73","doi-asserted-by":"publisher","first-page":"523","DOI":"10.13005\/bbra\/1302","volume":"11","author":"F Rezaei","year":"2014","unstructured":"Rezaei F, Nasser A, Jalilian FA, Hobbs Z, Azizian R (2014) Using phage as a highly specific antibiotic alternative against methicillin resistance Staphylococcus aureus (MRSA). Biosci Biotechnol Res Asia 11(2):523\u2013529","journal-title":"Biosci Biotechnol Res Asia"},{"issue":"11","key":"4349_CR74","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1093\/cid\/cix184","volume":"64","author":"N Dufour","year":"2017","unstructured":"Dufour N, Delattre R, Ricard J-D, Debarbieux L (2017) The lysis of pathogenic Escherichia coli by bacteriophages releases less endotoxin than by \u03b2-lactams. Clin Infect Dis 64(11):1582\u20131588","journal-title":"Clin Infect Dis"},{"key":"4349_CR75","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.654038","volume":"8","author":"L Walsh","year":"2021","unstructured":"Walsh L, Johnson CN, Hill C, Ross RP (2021) Efficacy of phage-and bacteriocin-based therapies in combatting nosocomial MRSA infections. Front Mol Biosci 8:654038","journal-title":"Front Mol Biosci"},{"issue":"7","key":"4349_CR76","doi-asserted-by":"publisher","first-page":"915","DOI":"10.3390\/antibiotics11070915","volume":"11","author":"M Hasan","year":"2022","unstructured":"Hasan M, Ahn J (2022) Evolutionary dynamics between phages and bacteria as a possible approach for designing effective phage therapies against antibiotic-resistant bacteria. Antibiotics 11(7):915","journal-title":"Antibiotics"},{"issue":"1","key":"4349_CR77","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1556\/1886.2023.00064","volume":"14","author":"JAG Fortaleza","year":"2024","unstructured":"Fortaleza JAG, Ong CJN, De Jesus R (2024) Efficacy and clinical potential of phage therapy in treating methicillin-resistant Staphylococcus aureus (MRSA) infections: a review. Euro J Microbiol Immunol 14(1):13\u201325","journal-title":"Euro J Microbiol Immunol"},{"issue":"5","key":"4349_CR78","doi-asserted-by":"publisher","first-page":"712","DOI":"10.18502\/ijm.v14i5.10967","volume":"14","author":"Z Rezaei","year":"2022","unstructured":"Rezaei Z, Elikaei A, Barzi SM, Shafiei M (2022) Isolation, characterization, and antibacterial activity of lytic bacteriophage against methicillin-resistant Staphylococcus aureus causing bedsore and diabetic wounds. Iran J Microbiol 14(5):712\u2013720. https:\/\/doi.org\/10.18502\/ijm.v14i5.10967","journal-title":"Iran J Microbiol"},{"issue":"6","key":"4349_CR79","first-page":"2675","volume":"16","author":"A Pradeep","year":"2023","unstructured":"Pradeep A, Ramasamy S, Emilda VJ, Kumar V (2023) Reassessing the forgotten cure: efficacy of bacteriophage as a therapeutic agent against MRSA in diabetic rats. Res J Pharm Technol 16(6):2675\u20132682","journal-title":"Res J Pharm Technol"},{"issue":"2","key":"4349_CR80","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0056022","volume":"8","author":"S Chhibber","year":"2013","unstructured":"Chhibber S, Kaur T, Sandeep K (2013) Co-therapy using lytic bacteriophage and linezolid: effective treatment in eliminating methicillin resistant Staphylococcus aureus (MRSA) from diabetic foot infections. PLoS ONE 8(2):e56022. https:\/\/doi.org\/10.1371\/journal.pone.0056022","journal-title":"PLoS ONE"},{"key":"4349_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12866-020-01891-8","volume":"20","author":"LG Kifelew","year":"2020","unstructured":"Kifelew LG, Warner MS, Morales S, Vaughan L, Woodman R, Fitridge R et al (2020) Efficacy of phage cocktail AB-SA01 therapy in diabetic mouse wound infections caused by multidrug-resistant Staphylococcus aureus. BMC Microbiol 20:1\u201310","journal-title":"BMC Microbiol"},{"key":"4349_CR82","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3389\/fmicb.2018.00561","volume":"9","author":"S Chhibber","year":"2018","unstructured":"Chhibber S, Kaur J, Kaur S (2018) Liposome entrapment of bacteriophages improves wound healing in a diabetic mouse MRSA infection. Front Microbiol 9:561. https:\/\/doi.org\/10.3389\/fmicb.2018.00561","journal-title":"Front Microbiol"},{"issue":"1","key":"4349_CR83","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s11262-023-02037-4","volume":"60","author":"J Jokar","year":"2024","unstructured":"Jokar J, Abdulabbas HT, Javanmardi K, Mobasher MA, Jafari S, Ghasemian A et al (2024) Enhancement of bactericidal effects of bacteriophage and gentamicin combination regimen against Staphylococcus aureus and Pseudomonas aeruginosa strains in a mice diabetic wound model. Virus Genes 60(1):80\u201396","journal-title":"Virus Genes"},{"issue":"12","key":"4349_CR84","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.3390\/antibiotics10121473","volume":"10","author":"B Mubeen","year":"2021","unstructured":"Mubeen B, Ansar AN, Rasool R, Ullah I, Imam SS, Alshehri S et al (2021) Nanotechnology as a novel approach in combating microbes providing an alternative to antibiotics. Antibiotics 10(12):1473","journal-title":"Antibiotics"},{"key":"4349_CR85","doi-asserted-by":"crossref","unstructured":"Bashabsheh RH, AL-Fawares Ol, Natsheh I, Bdeir R, Al-Khreshieh RO, Bashabsheh HH (2024) Staphylococcus aureus epidemiology, pathophysiology, clinical manifestations and application of nano-therapeutics as a promising approach to combat methicillin resistant Staphylococcus aureus. Pathogens Global Health 118(3):209\u2013231","DOI":"10.1080\/20477724.2023.2285187"},{"issue":"1","key":"4349_CR86","first-page":"5298565","volume":"2023","author":"J Hemmati","year":"2023","unstructured":"Hemmati J, Chegini Z, Arabestani MR (2023) Niosomal-based drug delivery platforms: a promising therapeutic approach to fight staphylococcus aureus drug resistance. J Nanomater 2023(1):5298565","journal-title":"J Nanomater"},{"issue":"1","key":"4349_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2023.101918","volume":"32","author":"A Alshweiat","year":"2024","unstructured":"Alshweiat A, Al-Khresieh RO, Alzarieni KZ, Rashaid AHB (2024) A significant antibiofilm and antimicrobial activity of chitosan-polyacrylic acid nanoparticles against pathogenic bacteria. Saudi Pharmaceut J 32(1):101918","journal-title":"Saudi Pharmaceut J"},{"issue":"5","key":"4349_CR88","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1007\/s10311-020-01033-6","volume":"18","author":"AB Sengul","year":"2020","unstructured":"Sengul AB, Asmatulu E (2020) Toxicity of metal and metal oxide nanoparticles: a review. Environ Chem Lett 18(5):1659\u20131683","journal-title":"Environ Chem Lett"},{"key":"4349_CR89","doi-asserted-by":"crossref","unstructured":"Li X, Wang L, Fan Y, Feng Q, Cui F-Z (2012) Biocompatibility and toxicity of nanoparticles and nanotubes. J Nanomater 2012(1):548389","DOI":"10.1155\/2012\/548389"},{"issue":"7","key":"4349_CR90","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1007\/s12011-020-02394-3","volume":"199","author":"F Fatima","year":"2021","unstructured":"Fatima F, Siddiqui S, Khan WA (2021) Nanoparticles as novel emerging therapeutic antibacterial agents in the antibiotics resistant era. Biol Trace Elem Res 199(7):2552\u20132564","journal-title":"Biol Trace Elem Res"},{"key":"4349_CR91","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.ijbiomac.2013.09.011","volume":"62","author":"BS Anisha","year":"2013","unstructured":"Anisha BS, Biswas R, Chennazhi KP, Jayakumar R (2013) Chitosan-hyaluronic acid\/nano silver composite sponges for drug resistant bacteria infected diabetic wounds. Int J Biol Macromol 62:310\u2013320. https:\/\/doi.org\/10.1016\/j.ijbiomac.2013.09.011","journal-title":"Int J Biol Macromol"},{"issue":"5","key":"4349_CR92","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202303042","volume":"13","author":"Z Bei","year":"2024","unstructured":"Bei Z, Zhang L, Li J, Tong Q, Shi K, Chen W et al (2024) A smart stimulation-deadhesion and antimicrobial hydrogel for repairing diabetic wounds infected with methicillin-resistant Staphylococcus aureus. Adv Healthc Mater 13(5):e2303042. https:\/\/doi.org\/10.1002\/adhm.202303042","journal-title":"Adv Healthc Mater"},{"key":"4349_CR93","doi-asserted-by":"publisher","unstructured":"Balcucho J, Narv\u00e1ez DM, Castro-Mayorga JL (2020) Antimicrobial and biocompatible polycaprolactone and copper oxide nanoparticle wound dressings against methicillin-resistant Staphylococcus aureus. Nanomaterials (Basel) 10(9). https:\/\/doi.org\/10.3390\/nano10091692","DOI":"10.3390\/nano10091692"},{"issue":"1","key":"4349_CR94","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1515\/ntrev-2021-0046","volume":"10","author":"AYH Nor Azlan","year":"2021","unstructured":"Nor Azlan AYH, Katas H, Mh Busra MF, Salleh NAM, Smandri A (2021) Metal nanoparticles and biomaterials: the multipronged approach for potential diabetic wound therapy. Nanotechnol Rev 10(1):653\u2013670","journal-title":"Nanotechnol Rev"},{"issue":"9","key":"4349_CR95","doi-asserted-by":"publisher","first-page":"6275","DOI":"10.1007\/s00210-024-03094-8","volume":"397","author":"M Saleem","year":"2024","unstructured":"Saleem M, Syed Khaja AS, Moursi S, Altamimi TA, Alharbi MS, Usman K et al (2024) Narrative review on nanoparticles based on current evidence: therapeutic agents for diabetic foot infection. Naunyn Schmiedebergs Arch Pharmacol 397(9):6275\u20136297","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"4349_CR96","first-page":"1","volume":"3","author":"S Abdollahi","year":"2012","unstructured":"Abdollahi S, Lotfipour F (2012) PLGA-and PLA-based polymeric nanoparticles for antimicrobial drug delivery. Biomed Int 3(1):1\u201311","journal-title":"Biomed Int"},{"key":"4349_CR97","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.106050","volume":"100","author":"RM Gebreel","year":"2024","unstructured":"Gebreel RM, Abdellatif MM, Attia A (2024) Lomefloxacin-loaded PLGA hollow nanospheres for healing MRSA-infected diabetic wound; optimization, in vitro and in vivo studies. J Drug Delivery Sci Technol 100:106050","journal-title":"J Drug Delivery Sci Technol"},{"issue":"2","key":"4349_CR98","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3390\/polym15020318","volume":"15","author":"A Al-Jipouri","year":"2023","unstructured":"Al-Jipouri A, Almurisi SH, Al-Japairai K, Bakar LM, Doolaanea AA (2023) Liposomes or extracellular vesicles: a comprehensive comparison of both lipid bilayer vesicles for pulmonary drug delivery. Polymers 15(2):318","journal-title":"Polymers"},{"key":"4349_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.msec.2021.111975","volume":"123","author":"F Davani","year":"2021","unstructured":"Davani F, Alishahi M, Sabzi M, Khorram M, Arastehfar A, Zomorodian K (2021) Dual drug delivery of vancomycin and imipenem\/cilastatin by coaxial nanofibers for treatment of diabetic foot ulcer infections. Mater Sci Eng C Mater Biol Appl 123:111975. https:\/\/doi.org\/10.1016\/j.msec.2021.111975","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"2","key":"4349_CR100","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1039\/B709883A","volume":"38","author":"J Kim","year":"2009","unstructured":"Kim J, Piao Y, Hyeon T (2009) Multifunctional nanostructured materials for multimodal imaging, and simultaneous imaging and therapy. Chem Soc Rev 38(2):372\u2013390","journal-title":"Chem Soc Rev"},{"key":"4349_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.134342","volume":"277","author":"Z Xu","year":"2024","unstructured":"Xu Z, Chen Z, Wang W, Meng X, Wang X, Xia Y et al (2024) Cuttlefish ink-derived melanin nanoparticle-embedded tremella fuciformis polysaccharide hydrogels for the treatment of MRSA-infected diabetic wounds. Int J Biol Macromol 277:134342","journal-title":"Int J Biol Macromol"},{"key":"4349_CR102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-021-01152-4","volume":"19","author":"Z Xu","year":"2021","unstructured":"Xu Z, Deng B, Wang X, Yu J, Xu Z, Liu P et al (2021) Nanofiber-mediated sequential photothermal antibacteria and macrophage polarization for healing MRSA-infected diabetic wounds. J Nanobiotechnol 19:1\u201321","journal-title":"J Nanobiotechnol"},{"issue":"37","key":"4349_CR103","doi-asserted-by":"publisher","first-page":"15937","DOI":"10.1039\/d1nr04687j","volume":"13","author":"R Zhang","year":"2021","unstructured":"Zhang R, Jiang G, Gao Q, Wang X, Wang Y, Xu X et al (2021) Sprayed copper peroxide nanodots for accelerating wound healing in a multidrug-resistant bacteria infected diabetic ulcer. Nanoscale 13(37):15937\u201315951. https:\/\/doi.org\/10.1039\/d1nr04687j","journal-title":"Nanoscale"},{"issue":"1","key":"4349_CR104","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s40824-023-00429-z","volume":"27","author":"J Zhao","year":"2023","unstructured":"Zhao J, Xu T, Sun J, Yuan H, Hou M, Li Z et al (2023) Multifunctional nanozyme-reinforced copper-coordination polymer nanoparticles for drug-resistance bacteria extinction and diabetic wound healing. Biomater Res. 27(1):88. https:\/\/doi.org\/10.1186\/s40824-023-00429-z","journal-title":"Biomater Res."},{"key":"4349_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2024.148790","volume":"481","author":"J Zheng","year":"2024","unstructured":"Zheng J, Deng Y, Zhao S, Liu L, Wang W, Li J et al (2024) Cascade-driven nanomotors promote diabetic wound healing by eradicating MRSA biofilm infection. Chem Eng J 481:148790","journal-title":"Chem Eng J"},{"key":"4349_CR106","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s13204-020-01630-5","volume":"11","author":"M Zubair","year":"2021","unstructured":"Zubair M, Husain FM, Qais FA, Alam P, Ahmad I, Albalawi T et al (2021) Bio-fabrication of titanium oxide nanoparticles from Ochradenus arabicus to obliterate biofilms of drug-resistant Staphylococcus aureus and Pseudomonas aeruginosa isolated from diabetic foot infections. Appl Nanosci 11:375\u2013387","journal-title":"Appl Nanosci"},{"issue":"9","key":"4349_CR107","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1039\/D0GC00734J","volume":"22","author":"GJ Soufi","year":"2020","unstructured":"Soufi GJ, Iravani S (2020) Eco-friendly and sustainable synthesis of biocompatible nanomaterials for diagnostic imaging: current challenges and future perspectives. Green Chem 22(9):2662\u20132687","journal-title":"Green Chem"},{"key":"4349_CR108","doi-asserted-by":"publisher","unstructured":"Steffy K, Shanthi G, Maroky AS, Selvakumar S (2018) Synthesis and characterization of ZnO phytonanocomposite using Strychnos nux-vomica L. (Loganiaceae) and antimicrobial activity against multidrug-resistant bacterial strains from diabetic foot ulcer. J Adv Res 9:69\u201377. https:\/\/doi.org\/10.1016\/j.jare.2017.11.001","DOI":"10.1016\/j.jare.2017.11.001"},{"issue":"2","key":"4349_CR109","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s10123-022-00293-2","volume":"26","author":"AM Ghanaim","year":"2023","unstructured":"Ghanaim AM, Foaad MA, Gomaa EZ, Dougdoug KAE, Mohamed GE, Arisha AH et al (2023) Bacteriophage therapy as an alternative technique for treatment of multidrug-resistant bacteria causing diabetic foot infection. Int Microbiol 26(2):343\u2013359","journal-title":"Int Microbiol"},{"issue":"8","key":"4349_CR110","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.clinthera.2023.06.009","volume":"45","author":"MJ Young","year":"2023","unstructured":"Young MJ, Hall LM, Merabishvilli M, Pirnay J-P, Clark JR, Jones JD (2023) Phage therapy for diabetic foot infection: a case series. Clin Ther 45(8):797\u2013801","journal-title":"Clin Ther"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-025-04349-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00284-025-04349-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-025-04349-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T08:38:52Z","timestamp":1757234332000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00284-025-04349-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,14]]},"references-count":110,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["4349"],"URL":"https:\/\/doi.org\/10.1007\/s00284-025-04349-0","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"value":"0343-8651","type":"print"},{"value":"1432-0991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,14]]},"assertion":[{"value":"22 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval Statement"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors have declared that no competing interests exist.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"384"}}